CRISPR-Cas9 Screens Unveil Potential New Targets for Glioblastoma (IMAGE)
Caption
Graham MacLeod, post-doctoral fellow at University of Toronto's Leslie Dan Faculty of Pharmacy used CRISPR-Cas9 screens to reverse engineer glioblastoma stem cells and uncovered potential new treatment targets. (Photo Credit: Steve Southon)
Credit
Steve Southon
Usage Restrictions
None
License
Licensed content